These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 380335)

  • 1. Combined modality treatment of Hodgkin's disease confined to lymph nodes. Results eight years later.
    Wiernik PH; Gustafson J; Schimpff SC; Diggs C
    Am J Med; 1979 Aug; 67(2):183-98. PubMed ID: 380335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A combined modality approach to the treatment of Hodgkin's disease. Preliminary results of a prospectively randomized clinical trial.
    O'Connell MJ; Wiernik PH; Brace KC; Byhardt RW; Greene WH
    Cancer; 1975 Apr; 35(4):1055-65. PubMed ID: 1116100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hodgkin's disease in childhood and adolescence: results of chemotherapy-radiotherapy in clinical stages IA-IIB.
    Cramer P; Andrieu JM
    J Clin Oncol; 1985 Nov; 3(11):1495-502. PubMed ID: 3903063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of stages I and II Hodgkin's disease with three different therapeutic modalities.
    Koziner B; Myers J; Cirrincione C; Redman J; Cunningham I; Caravelli J; Nisce LZ; McCormick B; Straus DJ; Mertelsmann R
    Am J Med; 1986 Jun; 80(6):1067-78. PubMed ID: 3755285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.
    Marcus KC; Kalish LA; Coleman CN; Shulman LN; Rosenthal DS; Canellos GP; Mauch PM
    J Clin Oncol; 1994 Dec; 12(12):2567-72. PubMed ID: 7989930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitrogen mustard, vincristine, procarbazine, and prednisolone for relapse after radiation in Hodgkin's disease. An analysis of long-term follow-up.
    Olver IN; Wolf MM; Cruickshank D; Worotniuk V; Ding JC; Cooper IA; Matthews JP
    Cancer; 1988 Jul; 62(2):233-9. PubMed ID: 3383124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic delivery of MOPP and ABVD combinations in Stage IV Hodgkin's disease: rationale, background studies, and recent results.
    Bonadonna G; Santoro A; Bonfante V; Valagussa P
    Cancer Treat Rep; 1982 Apr; 66(4):881-7. PubMed ID: 6176323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of advanced-stage massive mediastinal Hodgkin's disease: the case for combined modality treatment.
    Longo DL; Russo A; Duffey PL; Hubbard SM; Glatstein E; Hill JB; Jaffe ES; Young RC; DeVita VT
    J Clin Oncol; 1991 Feb; 9(2):227-35. PubMed ID: 1988570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: eight-year update of an Italian prospective randomized study.
    Biti GP; Cimino G; Cartoni C; Magrini SM; Anselmo AP; Enrici RM; Bellesi GP; Bosi A; Papa G; Giannarelli D
    J Clin Oncol; 1992 Mar; 10(3):378-82. PubMed ID: 1740677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early-stage Hodgkin's disease: long-term results with radiotherapy alone or combined radiotherapy and chemotherapy.
    Brusamolino E; Lazzarino M; Orlandi E; Canevari A; Morra E; Castelli G; Alessandrino EP; Pagnucco G; Astori C; Livraghi A
    Ann Oncol; 1994; 5 Suppl 2():101-6. PubMed ID: 7515642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.
    Weiner MA; Leventhal B; Brecher ML; Marcus RB; Cantor A; Gieser PW; Ternberg JL; Behm FG; Wharam MD; Chauvenet AR
    J Clin Oncol; 1997 Aug; 15(8):2769-79. PubMed ID: 9256118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternating drug combinations in the treatment of advanced Hodgkin's disease.
    Santoro A; Bonadonna G; Bonfante V; Valagussa P
    N Engl J Med; 1982 Apr; 306(13):770-5. PubMed ID: 6174865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stage III Hodgkin's disease: improved survival with combined modality therapy as compared with radiation therapy alone.
    Mauch P; Goffman T; Rosenthal DS; Canellos GP; Come SE; Hellman S
    J Clin Oncol; 1985 Sep; 3(9):1166-73. PubMed ID: 3839844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The intergroup Hodgkin's disease in children. A study of stages I and II.
    Gehan EA; Sullivan MP; Fuller LM; Johnston J; Kennedy P; Fryer C; Gilchrist GS; Hays DM; Hanson W; Heller R
    Cancer; 1990 Mar; 65(6):1429-37. PubMed ID: 2407336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of combined modality therapy in the treatment of stage IIIA Hodgkin's disease.
    DeVita VT
    Int J Radiat Oncol Biol Phys; 1979 Jun; 5(6):913-4. PubMed ID: 500419
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
    Fermé C; Eghbali H; Meerwaldt JH; Rieux C; Bosq J; Berger F; Girinsky T; Brice P; van't Veer MB; Walewski JA; Lederlin P; Tirelli U; Carde P; Van den Neste E; Gyan E; Monconduit M; Diviné M; Raemaekers JM; Salles G; Noordijk EM; Creemers GJ; Gabarre J; Hagenbeek A; Reman O; Blanc M; Thomas J; Vié B; Kluin-Nelemans JC; Viseu F; Baars JW; Poortmans P; Lugtenburg PJ; Carrie C; Jaubert J; Henry-Amar M;
    N Engl J Med; 2007 Nov; 357(19):1916-27. PubMed ID: 17989384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stage I and II Hodgkin's disease: involved-field radiotherapy versus extended-field radiotherapy versus involved-field radiotherapy followed by six cycles of MOPP.
    Hagemeister FB; Fuller LM; Velasquez WS; Sullivan JA; North L; Butler JJ; Johnston DA; Shullenberger CC
    Cancer Treat Rep; 1982 Apr; 66(4):789-98. PubMed ID: 7074649
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy.
    Santoro A; Bonadonna G; Valagussa P; Zucali R; Viviani S; Villani F; Pagnoni AM; Bonfante V; Musumeci R; Crippa F
    J Clin Oncol; 1987 Jan; 5(1):27-37. PubMed ID: 2433409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
    Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR
    Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.